Variant report

Variant	nsv964990
Chromosome Location	chr5:180109678-180114221
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:42)
CpG islands
(count:305)
Chromatin interactive
region (count:2)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:42 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr5:180110380-180110530	NB4	blood:	n/a	n/a
2	CTCF	chr5:180110398-180110465	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr5:180110220-180110370	A549	lung:	n/a	n/a
4	CTCF	chr5:180110300-180110450	MCF-7	breast:	n/a	n/a
5	CTCF	chr5:180110360-180110510	GM12878	blood:	n/a	n/a
6	CTCF	chr5:180110340-180110490	HepG2	liver:	n/a	n/a
7	CTCF	chr5:180110382-180110475	Spleen_OC	spleen:	n/a	n/a
8	CTCF	chr5:180110400-180110550	BE2_C	brain:	n/a	n/a
9	CTCF	chr5:180110360-180110422	Medullo	brain:	n/a	n/a
10	CTCF	chr5:180110380-180110530	BE2_C	brain:	n/a	n/a
11	CTCF	chr5:180110381-180110482	Lung_OC	lung:	n/a	n/a
12	CTCF	chr5:180110398-180110444	MCF-7	breast:	n/a	n/a
13	CTCF	chr5:180110324-180110522	K562	blood:	n/a	n/a
14	CTCF	chr5:180110573-180110640	Spleen_OC	spleen:	n/a	n/a
15	CTCF	chr5:180110360-180110510	GM06990	blood:	n/a	n/a
16	CTCF	chr5:180110340-180110490	Hela-S3	cervix:	n/a	n/a
17	CTCF	chr5:180110340-180110490	K562	blood:	n/a	n/a
18	CTCF	chr5:180110361-180110490	HepG2	liver:	n/a	n/a
19	CTCF	chr5:180110429-180110440	Medullo	brain:	n/a	n/a
20	CTCF	chr5:180110320-180110470	HRE	kidney:	n/a	n/a
21	CTCF	chr5:180110391-180110471	GM12878	blood:	n/a	n/a
22	CTCF	chr5:180110320-180110470	GM06990	blood:	n/a	n/a
23	CTCF	chr5:180110355-180110483	MCF-7	breast:	n/a	n/a
24	CTCF	chr5:180110352-180110444	Hela-S3	cervix:	n/a	n/a
25	CTCF	chr5:180110383-180110460	MCF-7	breast:	n/a	n/a
26	CTCF	chr5:180110422-180110460	GM19240	blood:	n/a	n/a
27	CTCF	chr5:180110383-180110431	LNCaP	prostate:	n/a	n/a
28	FOXA1	chr5:180114054-180114267	HepG2	liver:	n/a	n/a
29	FOXA2	chr5:180110604-180110895	HepG2	liver:	n/a	n/a
30	FOXA2	chr5:180113989-180114296	A549	lung:	n/a	n/a
31	POLR2A	chr5:180114018-180114047	A549	lung:	n/a	n/a
32	POLR2A	chr5:180113135-180113210	Gliobla	brain:	n/a	n/a
33	POLR2A	chr5:180113178-180113338	K562	blood:	n/a	n/a
34	POLR2A	chr5:180113980-180114048	MCF-7	breast:	n/a	n/a
35	POLR2A	chr5:180113992-180114013	A549	lung:	n/a	n/a
36	RAD21	chr5:180110243-180110532	H1-hESC	embryonic stem cell:	n/a	n/a
37	RAD21	chr5:180110307-180110479	K562	blood:	n/a	n/a
38	RAD21	chr5:180110259-180110517	H1-hESC	embryonic stem cell:	n/a	n/a
39	SP1	chr5:180110488-180110954	HepG2	liver:	n/a	n/a
40	USF1	chr5:180110721-180111030	H1-hESC	embryonic stem cell:	n/a	chr5:180110874-180110885
41	USF1	chr5:180110766-180110985	HepG2	liver:	n/a	chr5:180110874-180110885
42	USF1	chr5:180110736-180110976	HepG2	liver:	n/a	chr5:180110874-180110885

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:180111800-180111850	PANC-1	pancreas:	n/a
2	chr5:180112929-180112979	NT2-D1	testis:	n/a
3	chr5:180113361-180113411	NB4	blood:	n/a
4	chr5:180113361-180113411	ProgFib	skin:	n/a
5	chr5:180111800-180111850	LNCaP	prostate:	n/a
6	chr5:180112929-180112979	NH-A	brain:	n/a
7	chr5:180111800-180111850	Jurkat	blood:	n/a
8	chr5:180112929-180112979	U87	brain:	n/a
9	chr5:180111966-180112016	HRCEpiC	kidney:	n/a
10	chr5:180111966-180112016	AG09309	skin:	n/a
11	chr5:180111966-180112016	SK-N-MC	brain:	n/a
12	chr5:180113361-180113411	A549	lung:	n/a
13	chr5:180112929-180112979	HMEC	breast:	n/a
14	chr5:180113361-180113411	HRCEpiC	kidney:	n/a
15	chr5:180111800-180111850	HNPCEpiC	eye:	n/a
16	chr5:180111800-180111850	H1-hESC	embryonic stem cell:	embryo
17	chr5:180111966-180112016	NHDF-neo	bronchial:	n/a
18	chr5:180111966-180112016	HRE	kidney:	n/a
19	chr5:180111966-180112016	HEK293	kidney:	embryo
20	chr5:180111966-180112016	K562	blood:	n/a
21	chr5:180111800-180111850	HCT-116	colon:	n/a
22	chr5:180111800-180111850	HPAEpiC	pulmonary alveolar:	n/a
23	chr5:180113357-180113407	MCF-7	breast:	n/a
24	chr5:180112929-180112979	MCF10A-Er-Src	breast:	n/a
25	chr5:180113357-180113407	PANC-1	pancreas:	n/a
26	chr5:180113361-180113411	HCF	heart:	n/a
27	chr5:180112929-180112979	SKMC	muscle:	n/a
28	chr5:180113361-180113411	HCPEpiC	choroid plexus:	n/a
29	chr5:180113361-180113411	GM12892	blood:	n/a
30	chr5:180113357-180113407	GM12892	blood:	n/a
31	chr5:180112929-180112979	LNCaP	prostate:	n/a
32	chr5:180111800-180111850	Caco-2	colon:	n/a
33	chr5:180113361-180113411	CMK	blood:	n/a
34	chr5:180113361-180113411	BJ	skin:	n/a
35	chr5:180111800-180111850	AG09309	skin:	n/a
36	chr5:180113361-180113411	K562	blood:	n/a
37	chr5:180111966-180112016	PANC-1	pancreas:	n/a
38	chr5:180111800-180111850	PrEC	prostate:	n/a
39	chr5:180113357-180113407	AG04450	lung:	fetal
40	chr5:180111800-180111850	IMR90	lung:	fetal
41	chr5:180112929-180112979	T-47D	breast:	n/a
42	chr5:180113361-180113411	HMEC	breast:	n/a
43	chr5:180113357-180113407	SK-N-SH_RA	brain:	n/a
44	chr5:180113361-180113411	AG10803	skin:	n/a
45	chr5:180113361-180113411	HAEpiC	amniotic membrane:	n/a
46	chr5:180113361-180113411	NHDF-neo	bronchial:	n/a
47	chr5:180113357-180113407	HAEpiC	amniotic membrane:	n/a
48	chr5:180112929-180112979	ECC-1	luminal epithelium:	n/a
49	chr5:180111800-180111850	GM12891	blood:	n/a
50	chr5:180113361-180113411	T-47D	breast:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:180113673..180116367-chr5:180119581..180121156,3	K562	blood:
2	chr5:180048663..180050730-chr5:180113911..180116171,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CNOT6-3	chr5:180112649-180113546	XLOC_004682
2	lnc-CNOT6-3	chr5:180111766-180111906	XLOC_004682
3	lnc-CNOT6-3	chr5:180111765-180111906	NONHSAT105706
4	lnc-CNOT6-3	chr5:180112648-180113546	NONHSAT105706

No data

Variant related genes	Relation type
ENSG00000248717	TF binding region
ENSG00000248717	CpG island
ENSG00000236791	chromatin interactions

Extended variants
information (count: 187 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:187 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs543677506	chr5:180109742-180109743	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs189994395	chr5:180109751-180109752	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs529244126	chr5:180109805-180109806	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs549077279	chr5:180109807-180109808	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs116907064	chr5:180109811-180109812	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs528684688	chr5:180109812-180109813	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs551650074	chr5:180109867-180109868	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs571797331	chr5:180109873-180109874	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs537372196	chr5:180109905-180109906	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs146435220	chr5:180109906-180109907	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs139053376	chr5:180109916-180109917	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs141516599	chr5:180109920-180109921	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs555522186	chr5:180109957-180109958	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs147115217	chr5:180109976-180109977	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs182358257	chr5:180110064-180110065	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs138305568	chr5:180110082-180110083	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs200727711	chr5:180110146-180110147	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs577761751	chr5:180110174-180110175	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs79891729	chr5:180110191-180110192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs563204577	chr5:180110198-180110199	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs55907911	chr5:180110208-180110209	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs186669090	chr5:180110222-180110223	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs531142872	chr5:180110275-180110276	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs542586282	chr5:180110279-180110280	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs559437193	chr5:180110317-180110318	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs528613705	chr5:180110334-180110335	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs528454577	chr5:180110354-180110355	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs76426355	chr5:180110360-180110361	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs192520403	chr5:180110402-180110403	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs183885232	chr5:180110427-180110428	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs551299724	chr5:180110428-180110429	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs567930488	chr5:180110497-180110498	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs535458230	chr5:180110511-180110512	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs549031596	chr5:180110584-180110585	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs188530577	chr5:180110660-180110661	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs534464328	chr5:180110663-180110664	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs373234387	chr5:180110687-180110688	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs557821599	chr5:180110730-180110731	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs577773026	chr5:180110733-180110734	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs193132648	chr5:180110751-180110752	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs118019416	chr5:180110770-180110771	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs573567189	chr5:180110775-180110776	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs149625928	chr5:180110837-180110838	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs559350444	chr5:180110838-180110839	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs530894523	chr5:180110887-180110888	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs549977548	chr5:180110888-180110889	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs569723804	chr5:180110903-180110904	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs113814790	chr5:180110911-180110912	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs565333941	chr5:180110919-180110920	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs144337696	chr5:180110947-180110948	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Autism	22543975	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	23813976	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:45 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:180109200-180113600	Enhancers	Primary T helper cells fromperipheralblood	blood
2	chr5:180109200-180115800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
3	chr5:180109400-180109800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
4	chr5:180109600-180110600	Enhancers	Primary T cells from cord blood	blood
5	chr5:180109600-180112800	Enhancers	Primary T cells fromperipheralblood	blood
6	chr5:180109600-180115400	Enhancers	Fetal Thymus	thymus
7	chr5:180109600-180115400	Enhancers	Thymus	Thymus
8	chr5:180109600-180115600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
9	chr5:180109600-180116200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr5:180109800-180111200	Enhancers	HepG2	liver
11	chr5:180109800-180113000	Enhancers	Primary T helper naive cells from peripheral blood	blood
12	chr5:180109800-180116000	Enhancers	Primary T helper cells PMA-I stimulated	--
13	chr5:180110000-180110200	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
14	chr5:180110000-180110800	Enhancers	Dnd41	blood
15	chr5:180110000-180113600	Enhancers	Primary T killer memory cells from peripheral blood	blood
16	chr5:180110200-180110800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
17	chr5:180110200-180111000	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr5:180110400-180110800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
19	chr5:180110600-180111000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr5:180110600-180111000	Flanking Active TSS	Primary T cells from cord blood	blood
21	chr5:180110800-180112200	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
22	chr5:180110800-180113800	Weak transcription	Dnd41	blood
23	chr5:180110800-180116000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
24	chr5:180111000-180111400	Enhancers	Primary T cells from cord blood	blood
25	chr5:180111000-180115400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
26	chr5:180111200-180111600	Bivalent Enhancer	HepG2	liver
27	chr5:180111400-180111600	Flanking Active TSS	Primary T cells from cord blood	blood
28	chr5:180111400-180111800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
29	chr5:180111600-180111800	Flanking Bivalent TSS/Enh	HepG2	liver
30	chr5:180111600-180112400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
31	chr5:180111600-180115600	Enhancers	Primary T cells from cord blood	blood
32	chr5:180111800-180112000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
33	chr5:180111800-180112000	Bivalent Enhancer	HepG2	liver
34	chr5:180111800-180114600	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
35	chr5:180112200-180119400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
36	chr5:180112400-180114000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
37	chr5:180112400-180114800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
38	chr5:180112800-180114000	Weak transcription	Primary T cells fromperipheralblood	blood
39	chr5:180113000-180114000	Weak transcription	Primary T helper naive cells from peripheral blood	blood
40	chr5:180113600-180114600	Weak transcription	Primary T helper cells fromperipheralblood	blood
41	chr5:180113600-180114600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
42	chr5:180113800-180115000	Enhancers	Dnd41	blood
43	chr5:180114000-180114400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
44	chr5:180114000-180115400	Enhancers	Primary T helper naive cells from peripheral blood	blood
45	chr5:180114000-180116200	Enhancers	Primary T cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links